The rebound of platelet count could be a predictor of good prognosis of sepsis in the intensive care unit: a retrospective analysis of the large clinical database MIMIC-III
Abstract Background: The rise of platelets in sepsis patients with thrombocytopenia can lead to an improvement in clinical outcomes. We aimed to probe whether the rebound of platelet count could be a predictor of good prognosis in sepsis patients in a large, diverse population.Methods: All sepsis patients were initially stratified according to nadir platelet counts (very low<50´109/L, intermediate-low 50 ´ 109 to 99 ´ 109/L, low 100 ´ 109 to 149 ´ 109/L, normal 150 ´ 109 to 399 ´ 109/L, or thrombocytosis > 400 ´ 109/L). The delta platelet count (DPC) was defined as the difference between the last platelet count prior to transfer or death and the nadir platelet count after ICU admission. Results: A total of 3457 patients were enrolled in our study. The 28-day mortality in the very low (43.1%) and intermediate-low (36.9%) platelet count groups was higher than in the low (26.8%) and normal (23.2%) platelet count groups and thrombocytosis (18.2%) group (P <0.001). The patients in the ΔPC > 0 subgroup had lower 28-day morality (38.5% vs. 59.1%, P < 0.001, 33.3% vs. 44.7%, P = 0.015, 23.8% vs. 32.7% P = 0.01, 20.2 vs. 27.7, P = 0.001, respectively) except in the thrombocytosis group. The extended Cox proportional hazard regression model showed a decreased risk of death within 28 days in patients in the ΔPC > 0 subgroup (HR 0.570, 95% CI 0.498-0.651, P < 0.001).Conclusions: The rebound platelet count could be a biomarker of good prognosis in patients with sepsis.